Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

By F. Rodeghiero, R. Stasi, T. Gernsheimer, M. Michel, D. Provan, D. Arnold, J. Bussel, D. Cines, B. Chong, N. Cooper and 10 more. Blood, 2009

2,635 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Updated international consensus report on the investigation and management of primary immune thrombocytopenia. (2019, positive): “The ITP IWG recommends a treatment goal of a safe platelet count in the absence of bleeding, not a normal platelet count.(48) Nevertheless, platelet counts remain a focus for health care practitioners, whereas fatigue and mental health aspects are the major concerns of patients.”
International consensus report on the investigation and management of primary immune thrombocytopenia. (2010, background): “International consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan,1 Roberto Stasi,2 Adrian C. Newland,1 Victor S. Blanchette,3 Paula Bolton-Maggs,4 James B. Bussel,5 Beng H. Chong,6 Douglas B. Cines,7 Terry B. Gernsheimer,8 Bertrand Godeau,9 John Grain”
American Society of Hematology 2019 guidelines for immune thrombocytopenia. (2019, neutral): “During this rating process, the panel used definitions of the outcomes that were consistent with published terminology.(44) The list of definitions is available in Table 3.”